Q3 2015 Holdings
Filed 2015-11-16 | 25 holdings | $10.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $10.3M | 465,118 | 98.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $27.0K | 1,230,391 | 0.3% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $25.3K | 803,458 | 0.2% |
| Array Biopharma Inc | NOTE | 04269XAA3 | $22.2K | $22,534,000 | 0.2% |
| Retrophin Inc | COM | 761299106 | $20.4K | 1,007,660 | 0.2% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $19.2K | 1,492,700 | 0.2% |
| Assembly Biosciences Inc | COM | 045396108 | $18.0K | 1,887,069 | 0.2% |
| Kite Pharma Inc | COM | 49803L109 | $15.7K | 281,400 | 0.1% |
| Flex Pharma Inc | COM | 33938A105 | $11.2K | 933,691 | 0.1% |
| Atyr Pharma Inc(LIFEUSD) | COM | 002120103 | $8.6K | 840,462 | 0.1% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $7.9K | 835,530 | 0.1% |
| Kindred Biosciences Inc | COM | 494577109 | $6.9K | 1,323,431 | 0.1% |
| Genvec Inc | COM | 37246C307 | $4.6K | 1,986,413 | 0.0% |
| Celladon Corp | COM | 15117E107 | $3.0K | 2,843,170 | 0.0% |
| Oncothyreon Inc | COM | 682324108 | $2.6K | 943,500 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $2.4K | 100,709 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $2.4K | 101,995 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $2.3K | 149,000 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $2.3K | 415,480 | 0.0% |
| Gilead Sciences IncCall | COM | 375558903 | $2.1K | 3,255 | 0.0% |
| Orexigen Therapeutics Inc | COM | 686164104 | $2.0K | 937,958 | 0.0% |
| QLT Inc | COM | 746927102 | $1.7K | 638,900 | 0.0% |
| Valeant Pharmaceuticals IntlCall | COM | 91911K902 | $1.3K | 1,265 | 0.0% |
| Catalyst Biosciences Inc | COM | 14888D109 | $261 | 56,000 | 0.0% |
| Regulus Therapeutics IncCall | COM | 75915K901 | $35 | 1,280 | 0.0% |